Dan Lender

681 total citations
10 papers, 496 citations indexed

About

Dan Lender is a scholar working on Endocrinology, Diabetes and Metabolism, General Health Professions and Surgery. According to data from OpenAlex, Dan Lender has authored 10 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 3 papers in General Health Professions and 2 papers in Surgery. Recurrent topics in Dan Lender's work include Diabetes Management and Research (4 papers), Diabetes Management and Education (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). Dan Lender is often cited by papers focused on Diabetes Management and Research (4 papers), Diabetes Management and Education (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). Dan Lender collaborates with scholars based in United States and Israel. Dan Lender's co-authors include Charlene C. Quinn, Ann L. Gruber‐Baldini, James M. Minor, Philip Raskin, Carlos Arauz-Pacheco, Beverley Adams‐Huet, Malinda Peeples, Erik Barr, Michelle Shardell and Michael L. Terrin and has published in prestigious journals such as Diabetes, Hypertension and Diabetic Medicine.

In The Last Decade

Dan Lender

9 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dan Lender United States	8	284	224	78	67	56	10	496
Ananth Samith Shetty India	11	243 0.9×	285 1.3×	50 0.6×	73 1.1×	57 1.0×	15	537
Yuan Wu China	8	298 1.0×	233 1.0×	123 1.6×	120 1.8×	20 0.4×	20	522
Dominique Bird Australia	10	228 0.8×	185 0.8×	89 1.1×	67 1.0×	21 0.4×	24	371
Xianchao Xiao China	9	106 0.4×	126 0.6×	24 0.3×	48 0.7×	37 0.7×	21	323
Sundaram Selvam India	11	157 0.6×	456 2.0×	23 0.3×	120 1.8×	87 1.6×	15	714
Roy Harper United Kingdom	15	107 0.4×	275 1.2×	22 0.3×	68 1.0×	50 0.9×	40	717
Petra Povalej Slovenia	11	124 0.4×	65 0.3×	34 0.4×	29 0.4×	28 0.5×	37	451
Yoona Kim United States	9	106 0.4×	129 0.6×	25 0.3×	47 0.7×	69 1.2×	15	400
Amy Harris United States	8	63 0.2×	241 1.1×	24 0.3×	79 1.2×	57 1.0×	13	454

Countries citing papers authored by Dan Lender

Since Specialization

Citations

This map shows the geographic impact of Dan Lender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Lender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Lender more than expected).

Fields of papers citing papers by Dan Lender

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Lender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Lender. The network helps show where Dan Lender may publish in the future.

Co-authorship network of co-authors of Dan Lender

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Lender. A scholar is included among the top collaborators of Dan Lender based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Lender. Dan Lender is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Rosenstock, Julio, Dan Lender, David Guzman, et al.. (2025). 785-P: First Report on the Small Molecule Oral GLP-1 Receptor Agonist RGT-075 in Obesity—A Randomized, Placebo-Controlled Phase 2a Proof-of-Concept Twelve-Week Study. Diabetes. 74(Supplement_1). 1 indexed citations

Landau, Zohar, David C. Klonoff, Dan Lender, et al.. (2014). Improved pharmacokinetic and pharmacodynamic profiles of insulin analogues using InsuPatch, a local heating device. Diabetes/Metabolism Research and Reviews. 30(8). 686–692. 9 indexed citations

Quinn, Charlene C., Reneé Royak-Schaler, Dan Lender, et al.. (2011). Patient Understanding of Diabetes Self-Management: Participatory Decision-Making in Diabetes Care. Journal of Diabetes Science and Technology. 5(3). 723–730. 19 indexed citations

Quinn, Charlene C., Ann L. Gruber‐Baldini, Michelle Shardell, et al.. (2009). Mobile diabetes intervention study: Testing a personalized treatment/behavioral communication intervention for blood glucose control. Contemporary Clinical Trials. 30(4). 334–346. 55 indexed citations

Quinn, Charlene C., et al.. (2008). WellDoc ^™ Mobile Diabetes Management Randomized Controlled Trial: Change in Clinical and Behavioral Outcomes and Patient and Physician Satisfaction. Diabetes Technology & Therapeutics. 10(3). 160–168. 316 indexed citations

Lender, Dan, et al.. (2006). The Metabolic Syndrome and Cardiometabolic Risk: Scope of the Problem and Current Standard of Care. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(5P2). 3S–12S. 17 indexed citations

Lender, Dan, Carlos Arauz-Pacheco, Beverley Adams‐Huet, & Philip Raskin. (1997). Essential Hypertension Is Associated With Decreased Insulin Clearance and Insulin Resistance. Hypertension. 29(1). 111–114. 40 indexed citations

Fuller, Cindy J., Ahmad Agil, Dan Lender, & Ishwarlal Jialal. (1996). Superoxide production and LDL oxidation by diabetic neutrophils. Journal of Diabetes and its Complications. 10(4). 206–210. 12 indexed citations

Arauz-Pacheco, Carlos, Dan Lender, P. G. Snell, et al.. (1996). Relationship between insulin sensitivity, hyperinsulinemia, and insulin-mediated sympathetic activation in normotensive and hypertensive subjects. American Journal of Hypertension. 9(12). 1172–1178. 24 indexed citations

10.

Ramírez, Lorena, et al.. (1993). Insulin Requirements in Lipodystrophic Diabetes. Diabetic Medicine. 10(9). 863–865. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact